ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00360828
Brief Title: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

First Submitted : August 3, 2006
First Submitted that Met QC Criteria : August 3, 2006
First Posted : August 7, 2006 (Estimate)

Results First Submitted : October 3, 2011
Results First Submitted that Met QC Criteria : November 7, 2011
Results First Posted : December 9, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : February 20, 2017
Last Update Posted : March 23, 2017